These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32927897)

  • 1. Encapsulation of Nedaplatin in Novel PEGylated Liposomes Increases Its Cytotoxicity and Genotoxicity against A549 and U2OS Human Cancer Cells.
    El-Shafie S; Fahmy SA; Ziko L; Elzahed N; Shoeib T; Kakarougkas A
    Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32927897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.
    Alberts DS; Fanta PT; Running KL; Adair LP; Garcia DJ; Liu-Stevens R; Salmon SE
    Cancer Chemother Pharmacol; 1997; 39(6):493-7. PubMed ID: 9118460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines.
    Yamamoto K; Iwahana M; Kumazawa E; Kakihata K; Abe K; Hirano F; Tohgo A; Hoshiai H; Noda K
    Oncol Rep; 2003; 10(3):593-8. PubMed ID: 12684629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of PEGylated nedaplatin liposomes with sustained release behavior for enhancing the antitumor efficacy of non-small cell lung cancer.
    Tang J; Yang Z; Zhang Y; Huang R; Yu C; Yu C
    Int J Pharm; 2023 Mar; 635():122708. PubMed ID: 36764415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers.
    Monk BJ; Alberts DS; Burger RA; Fanta PT; Hallum AV; Hatch KD; Salmon SE
    Gynecol Oncol; 1998 Nov; 71(2):308-12. PubMed ID: 9826477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of liposomal technologies for delivery of platinum analogs in oncology.
    Liu D; He C; Wang AZ; Lin W
    Int J Nanomedicine; 2013; 8():3309-19. PubMed ID: 24023517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved pharmacological profile of the lipophilic antitumor dichloro-(N-dodecyl)-propanediamine-platinum(II) complex after incorporation into pegylated liposomes.
    Silva H; Silva AC; Lemos FO; Monte-Neto RL; Fontes AP; Lopes MT; Frézard F
    Anticancer Drugs; 2013 Feb; 24(2):131-9. PubMed ID: 23011234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum anticancer drugs. From serendipity to rational design.
    Monneret C
    Ann Pharm Fr; 2011 Nov; 69(6):286-95. PubMed ID: 22115131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
    Dadashzadeh S; Vali AM; Rezaie M
    Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer.
    Vermorken JB
    Int J Gynecol Cancer; 2001; 11 Suppl 1():21-30. PubMed ID: 11488999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nedaplatin enhanced apoptotic effects of ABT-737 in human cancer cells via Mcl-1 inhibition.
    Zhang C; Li YL; Weng X; Li LY; Zhou MX; Zhang DY; Lin NM
    Oncol Lett; 2016 Nov; 12(5):4195-4202. PubMed ID: 27895791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and cytotoxicity of cisplatin-containing liposomes.
    Carvalho Júnior AD; Vieira FP; Melo VJ; Lopes MT; Silveira JN; Ramaldes GA; Garnier-Suillerot A; Pereira-Maia EC; Oliveira MC
    Braz J Med Biol Res; 2007 Aug; 40(8):1149-57. PubMed ID: 17665053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of platinum compounds.
    Hartmann JT; Lipp HP
    Expert Opin Pharmacother; 2003 Jun; 4(6):889-901. PubMed ID: 12783586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective-Loading of Platinum-Chloroquine into PEGylated Neutral and Cationic Liposomes as a Drug Delivery System for Resistant Malaria Parasites.
    Ibrahim S; Tagami T; Ozeki T
    Biol Pharm Bull; 2017; 40(6):815-823. PubMed ID: 28566625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
    Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
    Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines.
    Tanaka R; Takii Y; Shibata Y; Ariyama H; Qin B; Baba E; Kusaba H; Mitsugi K; Harada M; Nakano S
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):279-85. PubMed ID: 15875187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic and therapeutic study of novel anti-tumor function of natural compound imperialine for treating non-small cell lung cancer.
    Lin Q; Qu M; Patra HK; He S; Wang L; Hu X; Xiao L; Fu Y; Gong T; He Q; Zhang L; Sun X; Zhang Z
    J Ethnopharmacol; 2020 Jan; 247():112283. PubMed ID: 31605736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of platinum-drug cytotoxicity in a human head and neck squamous cell carcinoma line and its platinum-resistant variant by liposomal amphotericin B and phospholipase A2-II.
    Ferguson PJ; Currie C; Vincent MD
    Drug Metab Dispos; 1999 Dec; 27(12):1399-405. PubMed ID: 10570020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin and platinum drugs at the molecular level. (Review).
    Boulikas T; Vougiouka M
    Oncol Rep; 2003; 10(6):1663-82. PubMed ID: 14534679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.